Search Results - "West, S.C"

Readmission Following Acute Myocarditis in Pediatric Patients by Knecht, K.R, Boyle, G, Butts, R, Deshpande, S.R, Gambetta, K, Lal, A.K, Richmond, M, West, S.C, Prada-Ruiz, C

Get full text

Impact of Initial Norwood Shunt Type on Young HLHS Patients Listed for Heart Transplant: A Multi-Institutional Study by Carlo, W.F, West, S.C, McCulloch, M, Naftel, D.C, Pruitt, E, Kirklin, J.K, Hubbard, M, Molina, K.M, Gajarski, R

Get full text

Pediatric Myocarditis: Variations in Immunotherapy and Impact on Outcomes by Gambetta, K, Boyle, G.J, Butts, R.J, Knecht, K.R, Lal, A.K, Law, Y, Prada-Ruiz, A, Richmond, M.E, West, S.C, Deshpande, S.R

Get full text

Risk Factors at Presentation Predict Outcomes of Pediatric Myocarditis: A Contemporary Multi-Center Cohort by West, S.C, Boyle, G.J, Butts, R.J, Deshpande, S.R, Gambetta, K, Knecht, K.R, Lal, A.K, Law, Y, Prada-Ruiz, A.C, Richmond, M

Get full text

Costs of Transplantation across a Positive Crossmatch by West, S.C, Webber, S.A, Miller, S.A, Wearden, P.D, Morell, V.O, Feingold, B

“…Purpose There is growing acceptance of the strategy of transplantation across a positive virtual crossmatch (XM) for highly allosensitized pediatric heart…”
Get full text

Predicting Myocardial Recovery in Children with Dilated Cardiomyopathy by West, S.C, Seckeler, M, Hallowell, S, Saunders, C.H, Jayakumar, K.A, Schneider, D.S

“…Purpose Dilated cardiomyopathy (DCM) is a common indication for heart transplantation (Tx) in children but not all progress to Tx. Standard 2D echocardiography…”
Get full text

Lymphoproliferative Disorders Late After Pediatric Heart Transplantation: A Multicenter Analysis by West, S.C, Friedland-Little, J.M, Schowengerdt, K, Naftel, D, Pruitt, E, Smith, K.S, Urschel, S, Michaels, M, Kirklin, J.K, Feingold, B

Get full text

BRCA2: a universal recombinase regulator by Thorslund, T, West, S C

“…Homologous recombination has a dual role in eukaryotic organisms. Firstly, it is responsible for the creation of genetic variability during meiosis by…”
Get full text

Alloantibody Reduction in Pediatric Heart Transplant Recipients by Rose-Felker, K., Zinn, M., West, S.C., Miller, S.A., Mangiola, M., Zeevi, A., Feingold, B.

“…Reduction in circulating alloantibodies is a common goal in treating antibody mediated rejection (AMR) and in desensitization of highly sensitized transplant…”
Get full text

Substrate specificity of the Escherichia coli RuvC protein. Resolution of three- and four-stranded recombination intermediates by BENSON, F. E, WEST, S. C

“…The specificity of the Escherichia coli RuvC Holliday junction resolvase has been investigated in vitro. RuvC protein cleaves synthetic DNA substrates that…”
Get full text

The choice of efficiency benchmarking metric in evaluating firm productivity and viability by West, S. C., Mugera, A. W., Kingwell, R. S.

“…The Debreu–Farrell measure of technical efficiency is widely used to benchmark firm performance. A limitation of this measure is that it is orientation…”
Get full text

Resolution of recombination intermediates by a mammalian activity functionally analogous to Escherichia coli RuvC resolvase by HYDE, H, DAVIES, A. A, BENSON, F. E, WEST, S. C

“…A mammalian endonuclease that resolves Holliday junctions has been partially purified from extracts of calf thymus and Chinese hamster ovary cells. The…”
Get full text

Branch migration of Holliday junctions promoted by the Escherichia coli RuvA and RuvB proteins. I. Comparison of RuvAB- and RuvB-mediated reactions by Müller, B, Tsaneva, I R, West, S C

“…The Escherichia coli RuvA and RuvB proteins mediate the branch migration of Holliday junctions in vitro. In the presence of stoichiometric amounts of RuvB (1…”
Get full text

Retransplantation: An Underutilized Resource or Only for a Select Few? by Alvarez, M. Vazquez, Pruitt, E., Deipanjan, N., Kemna, M.S., Urschel, S., West, S.C., Lin, K.Y., Lim, H.M., Allain-Rooney, T., Dipchand, A.I.

“…Outcomes after heart retransplantation (ReTx) have generally been reported as poorer than primary transplant and ReTx is offered variably around the world. We…”
Get full text

Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular Dysfunction by McCulloch, M.A., Knecht, K.R., Butts, R.J., Villa, C.R., Johnson, J.N., Conway, J., Bock, M.J., Lal, A.K., Schumacher, K.R., Law, S.P., Friedland-Little, J.M., Desphande, S.R., West, S.C., Lytrivi, I.D., Gambetta, K.E., Wittlieb-Weber, C.A.

“…Duchenne muscular dystrophy (DMD) is characterized by myocardial fibrosis and left ventricular (LV) dysfunction. Implantable cardioverter defibrillator (ICD)…”
Get full text

Electrocardiographic Trends in Boys with Duchenne Muscular Dystrophy by Gambetta, K., Wittlieb-Weber, C.W., Villa, C.R., Conway, J., Johnson, J.N., Bock, M.J., Lal, A.K., Schumacher, K.R., Law, S.P., Deshpande, S., West, S.C., Friedland-Little, J.M., Lytrivi, I.D., Butts, R.J., Knecht, K.J., Michael, M.A.

“…Little is known about sudden cardiac death risk and arrhythmias in boys with Duchenne muscular dystrophy(DMD). The goal of the study is to describe ECG…”
Get full text

Risk Factors for Cardiac Causes of Death in Males with Duchenne Muscular Dystrophy by Wittlieb-Weber, C.A., Knecht, K.K., Villa, C.R., Cunningham, C., Bock, M.J., Gambetta, K.E., Lal, A.K., Schumacher, K.R., Law, S.P., Deshpande, S.R., West, S.C., Friedland-Little, J.M., Lytrivi, I.D., McCulloch, M.A., Butts, R.J., Weber, D.R., Johnson, J.N.

“…As survival and neuromuscular function in Duchenne Muscular Dystrophy (DMD) have improved with glucocorticoid therapy and advances in respiratory care, the…”
Get full text

Utilization of Heart Failure Medications in Duchenne Muscular Dystrophy Patients with Left Ventricular Systolic Dysfunction by Lal, A.K., Wittlieb-Weber, C.A., Villa, C.R., Cunningham, C., Bock, M.J., Gambetta, K.E., Johnson, J.N., Schumacher, K.R., Law, S.P., Deshpande, S.R., West, S.C., Friedland-Little, J.M., Lytrivi, I.D., McCulloch, M.A., Ou, Z., Presson, A.P., Butts, R.J.

“…Current guidelines for the management of left ventricular systolic dysfunction (LVSD) in Duchenne Muscular Dystrophy (DMD) recommend angiotensin converting…”
Get full text

The Role of Prophylactic Heart Failure Therapy in Duchenne Muscular Dystrophy by Lal, A.K., Wittlieb-Weber, C.A., Villa, C.R., Conway, J., Bock, M.J., Gambetta, K.E., Schumacher, K.R., Law, S.P., Deshpande, S.R., West, S.C., Friedland-Little, J.M., Lytrivi, I.D., McCulloch, M.A., Butts, R.J., Knecht, K.R., Ou, Z., Presson, A.P., Johnson, J.N.

“…There is variable practice and debate surrounding prophylactic heart failure (HF) therapy in Duchenne Muscular Dystrophy (DMD) patients with normal systolic…”
Get full text

Practice variation in the diagnosis of acute rejection among pediatric heart transplant centers: An analysis of the pediatric heart transplant society (PHTS) registry by Godown, J., Cantor, R., Koehl, D., Cummings, E., Vo, J.B., Dodd, D.A., Lytrivi, I., Boyle, G.J., Sutcliffe, D.L., Kleinmahon, J.A., Shih, R., Urschel, S., Das, B., Carlo, W.F., Zuckerman, W.A., West, S.C., McCulloch, M.A., Zinn, M.D., Simpson, K.E., Kindel, S.J., Szmuszkovicz, J.R., Chrisant, M., Auerbach, S.R., Carboni, M.P., Kirklin, J.K., Hsu, D.T.

“…Freedom from rejection in pediatric heart transplant recipients is highly variable across centers. This study aimed to assess the center variation in methods…”
Get full text